MIR4716

Across TCGA pan-cancer cohorts, MIR4716 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR4716 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR4716 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4716 expression acts as an unfavorable survival marker.

HNSC, OV, and BLCA are the cancer types where MIR4716 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.278	0.664	.004	63	view →
OV	OS	Tertile	II,III,IV	0.198	0.331	.009	48	view →
BLCA	OS	Tertile	IV	0.160	0.600	<.001	36	view →
LUSC	DFS	Tertile	All	0.281	0.716	.005	24	view →
ACC	OS	Tertile	All	0.273	0.818	.031	15	view →
THCA	OS	Tertile	All	0.323	0.955	.014	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
ESCA	DFS	Tertile	All	0.395	0.835	.022	9	view →
SARC	OS	Tertile	All	0.258	0.734	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR4716–HNSC (OS)

Open the HNSC breakdown →